Patients who took a lower dose lost more weight on average. Read more at straitstimes.com. Read more at straitstimes.com.

In a Cleveland Clinic cohort, patients who stopped treatment for obesity had smaller weight losses to start, making these ...

ASCO Annual Meeting brought many different updates to light in the realm of hematological malignancies, including multiple ...

Novo Nordisk on Sunday said full results from two late-stage trials of its experimental weight-loss drug CagriSema show that ...

Fresh concerns have emerged about the platelet studies underpinning the FDA approval of ticagrelor, AstraZeneca's ...

Swim Across America hosts charity swims that fund cancer research across the country. The clinical trial it funds saved this ...

US biotech fund BVF Parners has sold its stake in drug developer Syntara, thus exiting all of its ASX life sciences exposures ...

Although antibiotics are routinely prescribed, many patients - more commonly women than men - either find the drugs don't ...

Eli Lilly & Co.’s experimental weight-loss pill helped patients shed pounds without serious side effects in a clinical trial, burnishing the drug’s blockbuster potential in the company’s compe ...

Recent advances in RAS-targeted therapies revolutionize treatment for gastrointestinal cancers, promising improved outcomes and new clinical strategies for oncologists.

CHICAGO -- Adding investigational cagrilintide to a GLP-1 receptor agonist increased weight loss in adults with obesity with ...

There is currently no cure for the disease nor any definitive way to predict how quickly Alzheimer’s disease will progress, ...